Looking back to 4 days ago, Exelixis Inc (NASD: EXEL) priced a 10,000,000 share secondary stock offering at $8.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their …
Exelixis, Inc. (NASDAQ:EXEL)‘s stock had its “outperform” rating reiterated by equities research analysts at William Blair in a note issued to investors on Saturday. Other equities research analysts have also issued …
Exel
Exelixis, Inc. (NASDAQ:EXEL) stated today that the European Commission (EC) has ratified CABOMETYX™ pills, which aim to cure advanced renal cell carcinoma (RCC) in grown-ups following vascular endothelial …
Exelixis, Inc. (NASDAQ:EXEL) EVP Peter Lamb sold 70,000 shares of the company’s stock in a transaction on Tuesday, January 3rd. The stock was sold at an average price of $14.65, for a total transaction of …
After suffering a big setback following a failed prostate cancer trial in 2014, Exelixis Inc. (NASDAQ:EXEL) has gone from dud to stud this ... Todd Campbell: Right, it's a mid-cap stock now, but it wasn't when you started …
The Motley Fool
No matter how many shares of Common Stock you own, please give venBio your proxy FOR the ... 10% of Exelixis, Inc.'s (Nasdaq: EXEL), 25% of Clovis Oncology, Inc.'s (Nasdaq: CLVS), and 30% of Array …
Exelixis, Inc. (Nasdaq:EXEL) announced that today it granted restricted stock unit awards (RSUs) representing an aggregate of 61,750 shares of Exelixis common stock and stock options to purchase an aggregate of 123,500 …
NASDAQ
Simon provides outperforming buy and sell opinions on stocks, currencies, bonds, commodities, and real estate. His in-depth research covers most of the major financial markets in America. His research is based on the …
Shares of Exelixis Inc. (EXEL) were up +0.39 or +8.37 percent in Tuesday’s premarket ... which will be marketed under the brand name CABOMETYX. Exelixis stock closed at $4.66 per share, up +0.25 or +5.67 percent in …
The both agree that institutional ownership can be dangerous because they move in and out of the market in very large blocks, so if something goes wrong, the stock’s value can tank if they sell. Exelixis, Inc. …
NASDAQ